Recruiting Obesity Studies in Mesa
Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE)
A randomized, double-blinded, placebo controlled study intended to capture cardiovascular outcomes during real-world use of naltrexone/bupropion (NB)....
Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus
A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NT-0796 as an Adjunct to a Reduced Calorie Diet and Increased Physical Activity in Obese Participan...
About Obesity Clinical Trials in Mesa
Obesity is a complex chronic disease involving an excessive amount of body fat that increases the risk of other diseases and health problems. It affects over 650 million adults worldwide. Treatment approaches include lifestyle modifications, medications (GLP-1 agonists), and bariatric surgery.
There are currently 2 obesity clinical trials recruiting participants in Mesa, ARIZONA. These studies are seeking a combined 8,762 participants. Research is being sponsored by Currax Pharmaceuticals, NodThera Limited. Clinical trial participation is free and participants receive study-related medical care at no cost.
Obesity Clinical Trials in Mesa — FAQ
Are there obesity clinical trials in Mesa?
Yes, there are 2 obesity clinical trials currently recruiting in Mesa, ARIZONA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Mesa?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Mesa research site will contact you about next steps.
Are clinical trials in Mesa free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Mesa studies also compensate for your time and travel.
What obesity treatments are being tested?
The 2 active trials in Mesa are testing new therapies including novel drugs, biologics, and treatment approaches for obesity.
Data updated March 2, 2026 from ClinicalTrials.gov